Medium materiality6/10
Spyre Therapeutics price target lowered to $121 from $132 at BTIG
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BTIG lowered Spyre Therapeutics target to $121; current price is $107.36.
- Target: $121 (from $132)
- Current price: $107.36
- Firm: BTIG
Key facts
- 01
Target: $121
- 02
Posted price: $107.36
- 03
Analyst firm: BTIG
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.